EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment and Characterization of a Stable hERG Cell Line for High-Throughput Drug Cardiac Safety Screening

Hailin Lu, Qingqing Guo, Qinling Qiu, Jiying Hu

International Journal of Molecular Sciences · 21.04.2026 · 27 (8) · 3701

DOI: 10.3390/ijms27083701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.04.2026. Verfasst von Hailin Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: High-Throughput Screening Center, Shenzhen Bay Laboratory, Shenzhen 518132, China. Hauptthemen laut MEDLINE: ERG1 Potassium Channel, High-Throughput Screening Assays. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Research Funding Program for Outgoing Postdocs in Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hERG potassium channel is critical for cardiac ventricular repolarization and a core target in pre-clinical drug safety screening. A robust, stable cell line with uniform, high hERG expression is essential for high-throughput assessments. In this study, we established a functional stable HEK293T cell line with high hERG expression. The hERG gene was subcloned into Lenti-HA-hERG-P2A-EGFP plasmid, in which GFP serves as a selection marker via a P2A self-cleaving peptide. GFP-positive monoclonal cells were isolated by fluorescence-activated cell sorting (FACS). Confocal imaging confirmed that hERG localized predominantly to the cell membrane, consistent with its physiological role. Manual patch-clamp revealed canonical hERG current properties: a small, stable current during depolarization to 20 mV, followed by a large outward tail current upon repolarization to −40 mV-a hallmark of hERG channel gating. Automated patch-clamp (APC)-based current profiling showed 93.5% of stable hERG cells exhibited peak tail currents > 50 pA (87% > 100 pA, with 49.5% > 400 pA), whereas 100% of blank HEK293T cells showed peak tail currents < 50 pA. Pharmacological validation with E-4031 demonstrated concentration-dependent inhibition of hERG currents, with an IC50 of 29.8 nM, which is consistent with literature-reported values. The stable hERG-expressing HEK293T cell line developed here exhibits consistent hERG expression, canonical channel function, and physiological sensitivity to hERG blockers. When paired with high-throughput APC systems, this cell model provides a robust, standardized platform for pre-clinical drug-induced hERG inhibition evaluation, aiding early detection of long QT syndrome risks and safer drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ERG1 Potassium ChannelHigh-Throughput Screening AssaysHumansHEK293 CellsPatch-Clamp TechniquesDrug Evaluation, PreclinicalPiperidinesPyridines

Stichwörter der Autor:innen

automated patch-clampdrug safety screeninghERG channelstable cell line

Substanzen

ERG1 Potassium ChannelKCNH2 protein, humanE 4031PiperidinesPyridines

Autor:innen und Institutionen

  • High-Throughput Screening Center, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • Biomedical Research Core Facility, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • Institute of Molecular Physiology, Shenzhen Bay Laboratory, Shenzhen 518132, China.

Förderung

  • Postdoctoral Research Funding Program for Outgoing Postdocs in Shenzhen

Zitieren

APA

Lu, H., Guo, Q., Qiu, Q., & Hu, J. (2026). Establishment and Characterization of a Stable hERG Cell Line for High-Throughput Drug Cardiac Safety Screening. International Journal of Molecular Sciences, 27(8), 3701. https://doi.org/10.3390/ijms27083701

Vancouver

Lu H, Guo Q, Qiu Q, Hu J. Establishment and Characterization of a Stable hERG Cell Line for High-Throughput Drug Cardiac Safety Screening. International Journal of Molecular Sciences. 2026;27(8):3701. doi:10.3390/ijms27083701

BibTeX
@article{Lu2026,
  author = {Lu, Hailin and Guo, Qingqing and Qiu, Qinling and Hu, Jiying},
  title = {Establishment and Characterization of a Stable hERG Cell Line for High-Throughput Drug Cardiac Safety Screening},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {3701},
  doi = {10.3390/ijms27083701}
}
Kostenlos starten →